Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cancer risk: an updated meta-analysis of observational studies.

Kayeong ShinJiwoo YangYeuni YuEunjeong SonKihun KimYun Hak Kim

Published in: Therapeutic advances in drug safety (2022)

Our results show some protective effects through the hazard ratio and some detrimental effects through the relative risk. Evidence supporting the risk of developing cancer is insufficient to prevent prescribing ACEIs or ARBs for patients with high blood pressure.

Keyphrases

angiotensin converting enzyme
angiotensin ii
blood pressure
systematic review
papillary thyroid
primary care
meta analyses
squamous cell
heart rate
randomized controlled trial
lymph node metastasis
young adults
squamous cell carcinoma
emergency department
case control
binding protein
metabolic syndrome